Dicerna Pharmaceuticals Inc (DRNA) Financials

$38.22

$0.00 (0.00%)

As on 29-Dec-2021EDT

Market cap

$2,978 Mln

Revenue (TTM)

$193 Mln

P/E Ratio

--

P/B Ratio

27.7

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12	Dec-11
Operating Revenue	192.85	164.31	23.90	6.18	2.28	0.30
Cost of Revenue	--	--	109.34	45.71	35.89	41.40
Gross Profit	192.85	164.31	23.90	6.18	2.28	0.30
Operating Expenses	314.12	277.52	152.09	67.40	62.86	60.04
Operating Profit (EBIT)	-121.27	-113.21	-128.19	-61.22	-60.59	-59.75
Other Income	-1.79	0.48	7.73	2.10	-5.61	0.24
Profit before Tax	-123.08	-112.75	-120.46	-88.85	-60.05	-59.51
Provision for Tax	1.36	--	--	--	--	--
Profit after Tax (Net Income)	-124.44	-112.75	-120.46	-88.85	-60.05	-59.51
Minority Interest	--	--	--	--	--	--
Consolidated Profit	-124.44	-112.75	-120.46	-88.85	-80.14	-59.51

Liabilities ($ Mln)	TTM	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12	Dec-11
Shareholder's Funds	107.66	137.75	152.20	200.69	101.24	41.21
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	425.10	392.15	203.48	114.29	3.00	--
Current Liabilities	239.30	177.94	241.74	94.06	16.65	10.04
Total Liabilities	1,015.35	707.85	597.41	409.04	120.88	51.25

Assets ($ Mln)	TTM	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12	Dec-11
Non-Current Assets	183.06	89.14	41.24	3.53	2.33	3.43
Current Assets	589.00	618.70	556.17	405.51	118.56	47.83
Total Assets	1,011.35	707.85	597.41	409.04	120.88	51.25
Total Debt*	64.42	52.18	23.50	--	--	--
Net Current Assets	349.71	440.77	314.43	311.46	101.91	--

Cashflow ($ Mln)	TTM	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12	Dec-11
Cash From Operating Activities	--	175.11	-0.69	18.30	-45.33	-48.75
Cash Flow from Investing Activities	--	-258.86	49.53	-202.73	-19.48	13.02
Cash from Financing Activities	--	59.42	52.89	169.88	112.73	0.53
Net Cash Inflow / Outflow	--	-24.33	101.73	-14.55	47.92	-35.19

Financials Ratios	TTM	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12	Dec-11
Adjusted EPS ($)	-1.64	-1.52	-1.77	-1.59	-2.73	-2.83
Cash EPS ($)	--	-1.49	-1.75	-1.57	-2.69	-2.83
Adjusted Book Value ($)	--	1.86	2.24	3.58	4.60	1.96
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	2.37	-0.01	0.33	-2.06	-2.32
Free Cash Flow per Share ($)	--	2.21	-0.10	0.32	-2.07	-2.34

Profitability Ratios	TTM	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12	Dec-11
ROCE (%)	--	-61.67	-64.01	-58.86	-84.31	-90.01
ROE (%)	-106.33	-77.77	-68.27	-58.86	-84.31	-90.01
ROA (%)	-12.88	-17.28	-23.94	-33.53	-69.77	-78.68
EBIT Margin (%)	-63.82	-68.61	-503.92	-1,428.92	-2,637.15	-20,253.56
Net Margin (%)	-65.13	-68.42	-380.79	-1,073.36	1,804.33	-11,228.87
Cash Profit Margin (%)	0.00	--	--	--	--	--

Growth Ratios	TTM	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12	Dec-11
Revenue Growth (%)	47.86	5.87	2.87	1.71	6.72	0.60
EBIT Growth (%)	-0.12	6.42	-36.49	-46.97	-0.50	5.20
Net Profit Growth (%)	-7.43	6.40	-35.57	-47.97	-0.90	5.29
EPS Growth (%)	-1.54	0.14	-0.12	0.42	0.04	0.10
Book Value Growth (%)	-32.65	--	--	--	--	--

Valuation Ratios	TTM	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12	Dec-11
Price / Earnings	--	-14.46	-12.44	-6.74	-3.31	-1.02
Price / Book Value	27.66	11.83	9.84	2.98	1.96	1.47
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	--	-10.08	-9.84	-3.38	-1.43	-0.25
Close Price ($)	20.16	22.03	22.03	10.69	9.03	2.88
High Price ($)	40.14	27.10	27.68	17.98	10.24	12.06
Low Price ($)	17.76	11.75	9.39	8.16	2.42	2.69
Market Cap ($ Cr)	2,977.70	--	--	--	--	--

Solvency Ratios	TTM	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12	Dec-11
Debt to Equity	--	0.38	0.15	--	--	--
Short term debt to equity ratio	0.05	0.02	0.02	--	--	--
Current Ratio	2.46	3.48	2.30	4.31	7.12	4.76
Quick Ratio	2.46	--	--	--	7.12	4.76
Interest Coverage	-5,593.64	--	--	--	--	--

Operating Efficiency Ratios	TTM	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12	Dec-11
Debtors to sales (%)	3.23	21.95	845.41	1,632.37	105.05	193.90
Asset Turnover	0.20	0.25	0.05	0.02	0.03	0.00
Receivable days	--	264.69	2,314.15	3,051.84	237.73	386.92
Inventory Days	--	--	--	--	--	--
Payable days	--	--	18.52	39.68	76.15	84.00
Cash Conversion Cycle	--	--	--	3,012.16	161.58	302.92

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.